Scientists say vaccine is likely to protect against UK Covid-19 variant
However, the BioNTech team says it is ready to adapt the Pfizer-BioNTech vaccine if needed in the future
20 January 2021 - 17:30
Pfizer and BioNTech have built the case that their Covid-19 vaccine will protect against the new variant of the coronavirus that emerged in the UK, with results of another lab trial.
Like previous work out of the University of Texas Medical Branch, the results published on Wednesday showed that antibodies in the blood of people who had been vaccinated were able to neutralise a version of the mutant virus that was created in the lab. The study was published on preprint server BioRxiv prior to peer review...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.